Jenny Murase, MD, describes how rising estrogen levels cause a shift in immune response from Th1 to Th2, causing potential atopic dermatitis exacerbations for patients who are pregnant.
Turn Therapeutics' Atopic Dermatitis Candidate Achieves 57% Reduction in Disease Severity in 7 Days
PODCAST: From Infection to Innovation - The Turn Therapeutics Story
Health Canada Authorizes Lebrikizumab for Moderate to Severe Atopic Dermatitis in Patients 12 Years and Older
The Cutaneous Connection: A Reminder of Patient Impact
Alexandra Golant, MD: Insights from Olympic Athlete Suni Lee's Journey with Atopic Dermatitis
Analyzing the Impact of AD on Women’s Sexual Health